Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
110.50    0.00 (0.00%)
Bid:
109.00
Ask:
112.00
Spread: 3.00 (2.752%)
Market Cap: £66.48m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Statement Re ActivIdentity Patent Claim

6 Oct 2008 07:00

RNS Number : 1139F
Intercede Group PLC
06 October 2008
 



6 OCTOBER 2008 

INTERCEDE GROUP plc

("Intercede" or "the Company")

Statement Relating To Possible Patent Infringement Suit

Intercede (AIM:IGP), the producer of the Intercede MyID™ Identity and Credential Management System, notes certain news reports indicating that ActivIdentity, formerly an Intercede business partner and OEM licensee of Intercede's smart card management software (see note 1 below), has filed an infringement suit against Intercede. 

Intercede has, to date, received no formal notification of action from ActivIdentity but after investigation has confirmed that a complaint was filed by ActivIdentity in the District Court of North California on 1 October 2008 concerning U.S. Patent 6,575,360. 

According to the details of the filing, this patent was issued to a 3rd party on 10 June 2003 and ownership was transferred to ActivIdentity on 6 July 2006. As such Intercede does not believe this patent was derived from ActivIdentity's own research and development activities.

As a software company, Intercede takes intellectual property rights very seriously and is scrupulous in protecting the rights of Intercede and other legitimate owners. Intercede retains leading patent lawyers to ensure that both its intellectual property and that of others is not infringed.

Intercede is aware of the '360' patent and has previously obtained expert opinion in the UK and US to confirm, beyond reasonable doubt, that none of its technology or products incorporate any intellectual property that may be protected by this patent.  

Intercede has previously discussed the patent at issue with ActivIdentity and was satisfied that it had demonstrated to ActivIdentity why none of Intercede's products infringe any valid claim of the patent. In the last eight months Intercede has received no communications from ActivIdentity to indicate they disagreed with this position.

 

Richard Parris, Chairman and Chief Executive of Intercede, said;

"The timing of this filing is questionable as it so closely follows recent press releases about Intercede's commercial successes in the US market. I believe ActivIdentity are resorting to the distraction tactic of litigation because their value proposition in the card management software market is failing (see note 2 below). Should ActivIdentity proceed with this action, Intercede will vigorously defend itself. 

As Intercede continues to achieve unprecedented commercial success with its technologically advanced solutions, it is inevitable that we will elicit a range of competitive responses from those companies who are threatened by Intercede's encroachment into their home markets. We welcome this particular challenge so that we can publicly demonstrate that the Intercede MyID system, supported by Intercede's own patented technology, is the most secure identity and credential management system available today. Unlike our competitors, all Intercede technology is developed in-house to ensure we do not rely on 3rd party originated intellectual property."

 

Intercede has today issued separately a positive trading update in respect of the 6 months ended 30 September 2008. Sales compared to the first half of the previous financial year have risen by 25% and a profit was generated at both pre and post tax level. The Directors of Intercede remain confident of the Company's future prospects.

Note 1: On 7 December 2001 and 23 April 2002, Intercede announced to the London Stock Exchange that ActivIdentity had paid Intercede an OEM license fee of $800,000 for an undisclosed number of Intercede MyID software licences (formerly branded as edefice). Full details of these announcements can be found on Intercede's web site, www.intercede.com.

Note 2: ActivIdentity reported a $2.0 million year-on-year decrease in card management software revenues in the 9 months to June 2008 (Source: Form10-Q Filing to the U.S. Securities and Exchange Commission for the Quarterly Period ended 30 June 2008). This is at a time when Intercede, a company focused exclusively on card management software, has experienced a substantial increase in revenues.

ENQUIRIES

Intercede Group plc

Tel. +44 (0)1455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

Pelham Public Relations

Tel. +44 (0)20 7743 6679

Archie Berens

Robert Koh

KBC Peel Hunt

Tel. + 44 (0)20 7418 8900

Richard Kauffer

Daniel Harris

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUUGAUUUPRGRA
Date   Source Headline
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.